1. NCMP-27. THE USE OF INTRAVENOUS IMMUNOGLOBULIN (IVIG) DURING SEVERE NEUROTOXICITY AMONG THE RECIPIENTS OF CHIMERIC ANTIGEN RECEPTOR T-CELLS (CAR-T) THERAPY. (9th November 2020) Authors: Mokhtari, Sepideh; Asquith, Justin; Bachmeier, Christina; Faramand, Rawan; Kim, Youngchul; Peguero, Edwin; Sahebjam, Solmaz; Jain, Michael; Vogelbaum, Michael; Davila, Marco; Forsyth, Peter; Locke, Frederick; Aleksandr, Lazaryan Journal: Neuro-oncology Issue: Volume 22(2020)Supplement 2 Page Start: ii128 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗